(Q38585273)

4 September 2017

Cell death mechanisms of plant-derived anticancer drugs: beyond apoptosis (English)

1 reference

4 September 2017

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26362468%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Nadine Darwiche

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26362468%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1

Hala Gali-Muhtasib

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26362468%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Raed Hmadi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26362468%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Mike Kareh

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26362468%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

11 September 2015

1 reference

4 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26362468%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26362468%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26362468%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

1531-1562

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26362468%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10495-015-1169-2

2 June 2020

exact match

0 references

cites work

Statistics: Attacking an epidemic

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

21 January 2018

Cancer statistics, 2015

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Cancer genes and the pathways they control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Targeting apoptosis pathways in cancer and perspectives with natural compounds from mother nature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

The Promise of Traditional Medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Traditional Arabic and Islamic Medicine, a Re-emerging Health Aid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Da-cheng-qi decoction, a traditional Chinese herbal formula, for intestinal obstruction: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

A public health agenda for traditional, complementary, and alternative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Potential health risks of complementary alternative medicines in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Epigenetic regulation by selected dietary phytochemicals in cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

A historical overview of natural products in drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Cell cycle modulatory and apoptotic effects of plant-derived anticancer drugs in clinical use or development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Programmed necrosis in the cross talk of cell death and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Dietary phytochemicals in cancer prevention and therapy: a complementary approach with promising perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Hydrolyzable tannin analysis in food.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Plant polyphenols: chemical properties, biological activities, and synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Dietary polyphenolic phytochemicals--promising cancer chemopreventive agents in humans? A review of their clinical properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Synthesis of gallotannins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Gas and liquid phase acidity of natural antioxidants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Role of hydrogen peroxide in bactericidal action of catechin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Resveratrol induces apoptotic cell death in rat H4IIE hepatoma cells but necrosis in C6 glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

The multiple mechanisms of cell death triggered by resveratrol in lymphoma and leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Resveratrol and calcium signaling: molecular mechanisms and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Resveratrol-induced autophagocytosis in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Identifying the estrogen receptor coactivator PELP1 in autophagosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Resveratrol inhibits glucose metabolism in human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Resveratrol-induced apoptosis depends on the lipid kinase activity of Vps34 and on the formation of autophagolysosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Resveratrol-mediated downregulation of Rictor attenuates autophagic process and suppresses UV-induced skin carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Phosphoproteomics reveals resveratrol-dependent inhibition of Akt/mTORC1/S6K1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Dihydroceramide intracellular increase in response to resveratrol treatment mediates autophagy in gastric cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Resveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/β-catenin signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Chronic treatment with resveratrol induces redox stress- and ataxia telangiectasia-mutated (ATM)-dependent senescence in p53-positive cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Resveratrol induces premature senescence in lung cancer cells via ROS-mediated DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Resveratrol induces cellular senescence with attenuated mono-ubiquitination of histone H2B in glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Resveratrol inhibits the growth of gastric cancer by inducing G1 phase arrest and senescence in a Sirt1-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Resveratrol and cancer: focus on in vivo evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Novel resveratrol and 5-fluorouracil coencapsulated in PEGylated nanoliposomes improve chemotherapeutic efficacy of combination against head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Targeting cancer stem cells by curcumin and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Curcumin: a promising agent targeting cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Curcumin a potent cancer preventive agent: Mechanisms of cancer cell killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Curcumin-induced autophagy contributes to the decreased survival of oral cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Curcumin induces autophagy in ACC-MESO-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Autophagic and apoptotic mechanisms of curcumin-induced death in K562 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Involvement of ROS in Curcumin-induced Autophagic Cell Death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Curcumin induces apoptosis-independent death in oesophageal cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Spermidine induces autophagy by inhibiting the acetyltransferase EP300.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Turmeric toxicity in A431 epidermoid cancer cells associates with autophagy degradation of anti-apoptotic and anti-autophagic p53 mutant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Antagonism between curcumin and the topoisomerase II inhibitor etoposide: a study of DNA damage, cell cycle regulation and death pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

bis-Dehydroxy-Curcumin triggers mitochondrial-associated cell death in human colon cancer cells through ER-stress induced autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

B19, a novel monocarbonyl analogue of curcumin, induces human ovarian cancer cell apoptosis via activation of endoplasmic reticulum stress and the autophagy signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Crosstalk from survival to necrotic death coexists in DU-145 cells by curcumin treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Curcumin, but not Prima-1, decreased tumor cell proliferation in the syngeneic murine orthotopic bladder tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

The mismatch repair system modulates curcumin sensitivity through induction of DNA strand breaks and activation of G2-M checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Post-translational modifications regulate microtubule function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

RNA binding protein CUGBP2/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Curcumin triggers p16-dependent senescence in active breast cancer-associated fibroblasts and suppresses their paracrine procarcinogenic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Bisdemethoxycurcumin suppresses MCF-7 cells proliferation by inducing ROS accumulation and modulating senescence-related pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Curcumin promotes differentiation of glioma-initiating cells by inducing autophagy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Genistein inhibits Brca1 mutant tumor growth through activation of DNA damage checkpoints, cell cycle arrest, and mitotic catastrophe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Genistein promotes cell death of ethanol-stressed HeLa cells through the continuation of apoptosis or secondary necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Multi-targeted therapy of cancer by genistein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Diet, autophagy, and cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Pharmaceutical regulation of telomerase and its clinical potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Chemopreventive and chemotherapeutic effects of genistein, a soy isoflavone, upon cancer development and progression in preclinical animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Genotoxicity of dietary, environmental and therapeutic topoisomerase II poisons is uniformly correlated to prolongation of enzyme DNA residence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Mechanisms of cancer chemoprevention by soy isoflavone genistein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

A journey under the sea: the quest for marine anti-cancer alkaloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Berberine, an epiphany against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Berberine: new perspectives for old remedies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: the contribution of autophagic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Berberine induces cell death in human hepatoma cells in vitro by downregulating CD147.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Berberine-induced apoptotic and autophagic death of HepG2 cells requires AMPK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Berberine-antiproliferative activity in vitro and induction of apoptosis/necrosis of the U937 and B16 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Protective effects of berberine on doxorubicin-induced nephrotoxicity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Berberine, a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Mitotic catastrophe: a mechanism for avoiding genomic instability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Antitumor effect of novel berberine derivatives in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Plasminogen activator inhibitor 1--insulin-like growth factor binding protein 3 cascade regulates stress-induced senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Berberine suppresses gero-conversion from cell cycle arrest to senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Berberine sulfate inhibits tumor-promoting activity of teleocidin in two-stage carcinogenesis on mouse skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

The anti-cancer activity of noscapine: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Induction of reactive oxygen species-mediated autophagy by a novel microtubule-modulating agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

9-bromonoscapine-induced mitotic arrest of cigarette smoke condensate-transformed breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Induction of robust de novo centrosome amplification, high-grade spindle multipolarity and metaphase catastrophe: a novel chemotherapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Noscapine crosses the blood-brain barrier and inhibits glioblastoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Colchicine: an old wine in a new bottle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

21 January 2018

Colchicine update: 2008.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Development of a novel tumor-targeted vascular disrupting agent activated by membrane-type matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Autophagic cell death, polyploidy and senescence induced in breast tumor cells by the substituted pyrrole JG-03-14, a novel microtubule poison

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Autophagy, cell death and sustained senescence arrest in B16/F10 melanoma cells and HCT-116 colon carcinoma cells in response to the novel microtubule poison, JG-03-14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Novel analogue of colchicine induces selective pro-death autophagy and necrosis in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Phase I clinical evaluation of ZD6126, a novel vascular-targeting agent, in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Disrupting tumour blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

New vascular disrupting agents in upper gastrointestinal malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

A polymeric colchicinoid prodrug with reduced toxicity and improved efficacy for vascular disruption in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Terpenoids: natural products for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

What made sesquiterpene lactones reach cancer clinical trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Perspectives on sesquiterpene lactones in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Parthenolide: from plant shoots to cancer roots

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Epigenetic mechanisms of plant-derived anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Parthenolide generates reactive oxygen species and autophagy in MDA-MB231 cells. A soluble parthenolide analogue inhibits tumour growth and metastasis in a xenograft model of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Inhibition of AMPK/autophagy potentiates parthenolide-induced apoptosis in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Parthenolide induces autophagy via the depletion of 4E-BP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Combined effects of FLT3 and NF-κB selective inhibitors on acute myeloid leukemia in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Triptolide: progress on research in pharmacodynamics and toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Triptolide binds covalently to a 90 kDa nuclear protein. Role of epoxides in binding and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Triptolide (TPL) inhibits global transcription by inducing proteasome-dependent degradation of RNA polymerase II (Pol II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Triptolide activates unfolded protein response leading to chronic ER stress in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Triptolide-mediated cell death in neuroblastoma occurs by both apoptosis and autophagy pathways and results in inhibition of nuclear factor-kappa B activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Autophagy regulates endoplasmic reticulum homeostasis and calcium mobilization in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Antitumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Triptolide therapy for neuroblastoma decreases cell viability in vitro and inhibits tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Betulinic Acid for cancer treatment and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Betulinic acid as a potent and complex antitumor phytochemical: a minireview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Betulinic acid and its derivatives: a patent review (2008-2013).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Proteomic investigation into betulinic acid-induced apoptosis of human cervical cancer HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Drugs that target specificity proteins downregulate epidermal growth factor receptor in bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Impairment of lysosomal integrity by B10, a glycosylated derivative of betulinic acid, leads to lysosomal cell death and converts autophagy into a detrimental process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Betulinic acid inhibits autophagic flux and induces apoptosis in human multiple myeloma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Betulinic acid-induced mitochondria-dependent cell death is counterbalanced by an autophagic salvage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Betulinic acid augments the inhibitory effects of vincristine on growth and lung metastasis of B16F10 melanoma cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Sp transcription factor family and its role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a:ZBTB10

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Pharmacological evaluation of C-3 modified Betulinic acid derivatives with potent anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Antioxidant functions of sulforaphane: a potent inducer of Phase II detoxication enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Sulforaphane causes autophagy to inhibit release of cytochrome C and apoptosis in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Suppression of microtubule dynamic instability and turnover in MCF7 breast cancer cells by sulforaphane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Covalent binding to tubulin by isothiocyanates. A mechanism of cell growth arrest and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Mechanism of sulforaphane-induced cell cycle arrest and apoptosis in human colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Development by self-digestion: molecular mechanisms and biological functions of autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Sulforaphane inhibits growth of phenotypically different breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Chemoprevention of prostate cancer by d,l-sulforaphane is augmented by pharmacological inhibition of autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Reactive oxygen species-related induction of multidrug resistance-associated protein 2 expression in primary hepatocytes exposed to sulforaphane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Sulforaphane retards the growth of UM-UC-3 xenographs, induces apoptosis, and reduces survivin in athymic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Die another way--non-apoptotic mechanisms of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Anti-apoptotic mechanisms of drug resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Self-consumption: the interplay of autophagy and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Autophagy: dual roles in life and death?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Deconvoluting the context-dependent role for autophagy in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Targeting cancer stem cells to suppress acquired chemotherapy resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Tumor heterogeneity in the clinic: is it a real problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Regulation of tumor growth and metastasis: the role of tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

The use of plant-derived bioactive compounds to target cancer stem cells and modulate tumor microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Immunogenic cell death in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2

Polyphenol/peptide binding and precipitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1169-2